Literature DB >> 6514010

The transport of (+)-amphetamine by the neuronal noradrenaline carrier.

H Bönisch.   

Abstract

PC-12 cells (a clonal line of rat phaeochromocytoma cells) take up noradrenaline by a transport system which is identical with the neuronal amine transport system ("uptake1"). The uptake of 3H-noradrenaline into reserpine-pretreated PC-12 cells (monoamine oxidase inhibited) was saturable (Km = 0.6 +/- 0.1 mumol/l), dependent on sodium and chloride, and competitively inhibited by (+)-amphetamine (Ki = 0.18 +/- 0.04 mumol/l), cocaine (Ki = 0.55 +/- 0.15 mumol/l) and desipramine (Ki = 4.3 +/- 0.6 nmol/l). The uptake and accumulation of 3H (+)-amphetamine showed characteristics comparable to those of 3H-noradrenaline, since the uptake of 3H (+)-amphetamine (0.1 mumol/l) was reduced by omission of sodium or chloride from the incubation medium. The sodium-sensitive component of uptake and accumulation of 3H (+)-amphetamine was fully inhibited by cocaine and desipramine. The IC50 of desipramine for inhibition of the sodium-sensitive component of the 1-min uptake of 3H (+)-amphetamine (20 nmol/l) was about 2 nmol/l, i.e., identical with the Ki for inhibition of uptake of 3H-noradrenaline. At concentrations above 1 mumol/l, desipramine additionally caused an inhibition of the sodium-independent permeation of 3H (+)-amphetamine into PC-12 cells. Hence, by using a homogeneous population of cells endowed with "uptake1", it is possible to demonstrate - besides a pronounced lipophilic entry - a carrier-mediated uptake of 3H (+)-amphetamine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514010     DOI: 10.1007/bf00506235

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  A major role for chloride in (3H)- noradrenaline transport by rat heart adrenergic nerves.

Authors:  S Sánchez-Armáss; F Orrego
Journal:  Life Sci       Date:  1977-06-01       Impact factor: 5.037

3.  Accumulation of (-)-14C-ephedrine by the pigmented and the nonpigmented iris.

Authors:  P N Patil; K Shimada; D R Feller; L Malspeis
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

4.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

5.  Effect of antidepressant and neuroleptic drugs on respiratory function of rat heart mitochondria.

Authors:  E Bachmann; G Zbinden
Journal:  Biochem Pharmacol       Date:  1979-12-15       Impact factor: 5.858

6.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

7.  Presence of a high affinity uptake system for catecholamines in cultured bovine adrenal chromaffin cells.

Authors:  R L Kenigsberg; J M Trifaró
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

8.  Large-scale preparation of plasma membrane vesicles from PC-12 pheochromocytoma cells and their use in noradrenaline transport studies.

Authors:  R Harder; H Bönisch
Journal:  Biochim Biophys Acta       Date:  1984-08-08

9.  Characteristics of accumulation of ephedrine in rabbit atria.

Authors:  D S Golko; D M Paton
Journal:  Can J Physiol Pharmacol       Date:  1976-04       Impact factor: 2.273

10.  Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells.

Authors:  L A Greene; G Rein
Journal:  Brain Res       Date:  1977-07-01       Impact factor: 3.252

View more
  23 in total

1.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

2.  Expression of the neuronal noradrenaline transporter in Xenopus laevis oocytes.

Authors:  D Coppeneur; B Lingen; G Sanders; M C Dabauvalle; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

3.  Neurotransmitter and psychostimulant recognition by the dopamine transporter.

Authors:  Kevin H Wang; Aravind Penmatsa; Eric Gouaux
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

4.  Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.

Authors:  E Schömig; M Körber; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

5.  Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.

Authors:  E Schömig; J Michael-Hepp; C L Schönfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

6.  The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.

Authors:  E Schömig; P Fischer; C L Schönfeld; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

7.  The neuronal noradrenaline transport system of PC-12 cells: kinetic analysis of the interaction between noradrenaline, Na+ and Cl- in transport.

Authors:  U Friedrich; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

8.  N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-21       Impact factor: 3.000

9.  High-affinity uptake of noradrenaline in postsynaptic neurones.

Authors:  S al-Damluji; L Z Krsmanovic; K J Catt
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Biphasic mechanisms of amphetamine action at the dopamine terminal.

Authors:  Cody A Siciliano; Erin S Calipari; Mark J Ferris; Sara R Jones
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.